Showing results (2091-2100 of 2,492) with videos related to

Sort By:
Pageof 250
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 31, 2019
A Phase Ib/II Study of Ramucirumab in Combination with Emibetuzumab in Patients with Advanced CancerJames J Harding, Andrew X Zhu, Todd M Bauer, et al.
Neoplasia (New York, N.Y.)|June 8, 2019
Induced Chromosomal Aneuploidy Results in Global and Consistent Deregulation of the Transcriptome of Cancer CellsDarawalee Wangsa, Rüdiger Braun, Christina H Stuelten, et al.
The Journal of Allergy and Clinical Immunology|May 20, 2023
Single-cell RNA sequencing defines disease-specific differences between chronic nodular prurigo and atopic dermatitisNatalia Alkon, Frank P Assen, Tamara Arnoldner, et al.
International Journal of Cardiology|September 6, 2021
Ventricular assist devices in paediatric cardiomyopathy and congenital heart disease: An analysis of the German National Register for Congenital Heart DefectsAstrid Elisabeth Lammers, Katharina Sofie Sprenger, Gerhard-Paul Diller, et al.
Interactive Cardiovascular and Thoracic Surgery|August 26, 2021
Pulmonary valve prostheses: patient's lifetime procedure load and durability. Evaluation of the German National Register for Congenital Heart DefectsDietmar Boethig, Murat Avsar, Ulrike M M Bauer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Phase I Study of 2- or 3-Week Dosing of Telisotuzumab Vedotin, an Antibody-Drug Conjugate Targeting c-Met, Monotherapy in Patients with Advanced Non-Small Cell Lung CarcinomaD Ross Camidge, Daniel Morgensztern, Rebecca S Heist, et al.
International Neurourology Journal|July 5, 2017
Targeting Moderate and Severe Male Stress Urinary Incontinence With Adjustable Male Slings and the Perineal Artificial Urinary Sphincter: Focus on Perioperative Complications and Device ExplantationsAlexander Kretschmer, Tanja Hüsch, Frauke Thomsen, et al.
The Lancet. Oncology|November 1, 2019
Lorlatinib in advanced ROS1-positive non-small-cell lung cancer: a multicentre, open-label, single-arm, phase 1-2 trialAlice T Shaw, Benjamin J Solomon, Rita Chiari, et al.
Molecular Phylogenetics and Evolution|October 13, 2024
A multi-gene phylogeny of the Asian kukri snakes (Oligodon Fitzinger, 1826): Sharpening the blade of the second largest serpent radiation (Reptilia: Squamata: Colubridae)Justin L Lee, Platon V Yushchenko, Chatmongkon Suwannapoom, et al.
Breast Cancer Research and Treatment|August 2, 2019
A phase Ib, open-label, dose-escalation study of the safety and pharmacology of taselisib (GDC-0032) in combination with either docetaxel or paclitaxel in patients with HER2-negative, locally advanced, or metastatic breast cancerVandana G Abramson, Mafalda Oliveira, Andrés Cervantes, et al.
Pageof 250